In today’s Bulldog wrapup of technology and life science news:

  • Pozen resubmits a drug application
  • Amazon to fight FTC over kid apps purchases
  • Furiex and Quintiles deals close
  • Twitter names a new CFO

The details:

  • Pozen Resubmits New Drug Application

CHAPEL HILL – Pozen (Nasdaq: POZN) has resubmitted a new drug application for a new pain reliever, saying that production concerns raised by the FDA have been addressed. 

“Our API supplier has been working to respond to the observations contained in the FDA inspector’s report. We recently completed our own onsite audit, and we understand that the supplier has now submitted a supplement to its May 9, 2014 initial response to the FDA,” said John Plachetka, chairman, president and CEO of Pozen. “Based upon the available information, we believe there are actions in place that address the deficiencies noted by FDA.”

  • Amazon vows to fight FTC on kids in-app purchases

LOS ANGELES — Amazon said Wednesday that it is prepared to go to court against the Federal Trade Commission to defend itself against charges that it has not done enough to prevent children from making unauthorized in-app purchases.

The FTC alleged in a draft lawsuit released by Amazon that unauthorized charges by children on Amazon tablets have amounted to millions of dollars.

Seattle-based Inc. said in a letter Tuesday to FTC Chairwoman Edith Ramirez that it had already refunded money to parents who complained. It also said its parental controls go beyond what the FTC required from Apple when it imposed a $32.5 million fine on the company in January over a similar matter.

  • Quintiles Closes Encore Health Acquisition

RESEARCH TRIANGLE PARK –  Quintiles (NYSE: Q) has closed acquisition of Encore Health Resources, a provider of healthcare analytics and consulting services.

Financial terms were not disclosed.

“We are extremely pleased to have completed the acquisition of Encore,” said Scott Evangelista, president, Integrated Commercial Services and Solutions at Quintiles. “The addition of Encore greatly enhances our electronic health records expertise – an area that continues to grow in importance as payers, providers and biopharmaceutical customers increase their focus on real-world evidence. We are excited about working together with the Encore team and leveraging the expertise each organization possesses to help our customers improve their probability of success.”

  • Forest Labs’ Acquisition of Furiex Closes

MORRISVILLE – Nearly 80 percent of shareholders in Furiex Pharmaceuticals voted to approve the company’s more-than-$1 billion acquisition by Forest Labs this week.

The deal officially closed on Wednesday, Forest Labs announced.

  • Twitter names Goldman Sachs executive to CFO post

SAN FRANCISCO — Twitter is hiring a Goldman Sachs executive as its new chief financial officer, continuing a shake-up that has led to the departures of several executives in recent months.

The social media company said in a regulatory filing Tuesday that it hired Anthony Noto, 46, to replace current CFO Mike Gupta, who steered Twitter through its initial public offering in 2013.

Gupta will stay on at Twitter, taking on the role of senior vice president for strategic investments.